InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Mulroy Michael H., Director. Director active across 1 companies, notably Lineage Cell Therapeutics, Inc.. In total, 3 reports have been logged. Total volume traded: €9k. The latest transaction was filed on 24 March 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
€8,9047,000 shares@ €1.2720.0022% mcap8.9% of flow
Common Shares, no par value
SEC:0001493152-22-007754:0·
Ideal exit: 19 Dec 2022 (T+270)
€45,64924,720 shares@ €1.8467100.0% of flow
Common Shares, no par value
SEC:0001493152-21-014860·
€45,64924,720 shares@ €1.84670.011% mcap45.6% of flow
Common Shares, no par value
SEC:0001493152-21-014860:0·
3 of 3 declarations
About Mulroy Michael H.
Michael H. Mulroy is a Board Member at Lineage Cell Therapeutics, Inc. With expertise in the biotechnology sector, he oversees the development and innovation strategies of the company. His role is crucial in ensuring the growth and sustainability of Lineage.
